Andy Morley
Principal at O2h Ventures
About
A medicinal chemist with over 25 years in major pharma (Sanofi-Aventis, AstraZeneca) who leads scientific evaluation of investments at o2h Ventures. He is an inventor on 55+ publications and patents and serves as CSO of Opal Oncology.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures
Gary Pitts
Compliance Consultant, Tetractys Limited at O2h Ventures